Document ID: chunk:federal_register_of_legislation:F2023L00223:clause:1_50
Version: federal_register_of_legislation:F2023L00223
Segment Type: clause
Provision Reference: sch 1 cl 50
Character Range: 90065–90947

50            Symptomatic hypoglycaemia due to metastatic tumour (usually insulinoma), uncontrolled by medication (such as diazoxide).

    Notes to Table 3.3
      1. For the purposes of Table 3.3, the degree of control is defined by reference to the glycated haemoglobin measurement (HbA1c) where:
        (i)        4%-6% is the non-diabetic range; and
        (ii)      <8% is indicative of satisfactory control for the purposes of this table.
2.     'Significant neuropathy' means persistent symptoms of peripheral or autonomic neuropathy which interfere with quality of life to a considerable degree.
3.     'Type 2' means non-insulin dependent diabetes mellitus.
4.     'Type 1' means insulin dependent diabetes mellitus and other forms of diabetes requiring insulin, such as Cystic Fibrosis related diabetes and Type 3c diabetes.

     3.4        Gonads and mammary glands